These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Angiogenesis as risk factor for plaque vulnerability. Di Stefano R; Felice F; Balbarini A Curr Pharm Des; 2009; 15(10):1095-106. PubMed ID: 19355951 [TBL] [Abstract][Full Text] [Related]
4. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Virmani R; Kolodgie FD; Burke AP; Finn AV; Gold HK; Tulenko TN; Wrenn SP; Narula J Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2054-61. PubMed ID: 16037567 [TBL] [Abstract][Full Text] [Related]
5. Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice. Van der Veken B; De Meyer GRY; Martinet W Vascul Pharmacol; 2018 Jan; 100():34-40. PubMed ID: 29079346 [TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in the atherosclerotic plaque. Camaré C; Pucelle M; Nègre-Salvayre A; Salvayre R Redox Biol; 2017 Aug; 12():18-34. PubMed ID: 28212521 [TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization. Jain RK; Finn AV; Kolodgie FD; Gold HK; Virmani R Nat Clin Pract Cardiovasc Med; 2007 Sep; 4(9):491-502. PubMed ID: 17712362 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological strategies to inhibit intra-plaque angiogenesis in atherosclerosis. Perrotta P; Emini Veseli B; Van der Veken B; Roth L; Martinet W; De Meyer GRY Vascul Pharmacol; 2019 Jan; 112():72-78. PubMed ID: 29933080 [TBL] [Abstract][Full Text] [Related]
9. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? Kolodgie FD; Narula J; Yuan C; Burke AP; Finn AV; Virmani R J Am Coll Cardiol; 2007 May; 49(21):2093-101. PubMed ID: 17531658 [TBL] [Abstract][Full Text] [Related]
11. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease. Sedding DG; Boyle EC; Demandt JAF; Sluimer JC; Dutzmann J; Haverich A; Bauersachs J Front Immunol; 2018; 9():706. PubMed ID: 29719532 [TBL] [Abstract][Full Text] [Related]
13. Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis. Chistiakov DA; Melnichenko AA; Myasoedova VA; Grechko AV; Orekhov AN Ann Med; 2017 Dec; 49(8):661-677. PubMed ID: 28797175 [TBL] [Abstract][Full Text] [Related]
14. [Neoplasms and angiogenesis]. Lewy-Trenda I Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576 [TBL] [Abstract][Full Text] [Related]
15. [Mechanisms and potential of the therapeutic stimulation of arteriogenesis]. Schirmer SH; van Royen N; Laufs U; Böhm M Dtsch Med Wochenschr; 2009 Feb; 134(7):302-6. PubMed ID: 19197812 [TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical interventions to influence arteriogenesis: new concepts to treat ischemic heart disease. Hoefer IE; Piek JJ; Pasterkamp G Curr Med Chem; 2006; 13(9):979-87. PubMed ID: 16611079 [TBL] [Abstract][Full Text] [Related]